...
GMRESMALL

Global Medical REIT Inc.

Real EstateREIT - Healthcare Facilities
$37.20
$0.01(+3.62%)
52W$29.05
$45.75
FinancialsValuationvs HR
Updated Feb 28, 12:00 AM
RSI54
RS Rating66/99
Beta0.58
Volatility33%
F-Score4/9
Mkt Cap$499M
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

Global Medical REIT Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is moderate (RS Rating: 66), indicating performance broadly in line with the market. Earnings contraction of 166% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.

Relative Strength
66
out of 99
Average
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
0.58
vs S&P 500
DEFENSIVE
52W Position
49%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$35.22
50 SMA > 100 SMA$33.68
100 SMA > 150 SMA$34.29
150 SMA > 200 SMA$34.05

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$35.80+3.90%ABOVE
50 SMA$35.22+5.64%ABOVE
100 SMA$33.68+10.46%ABOVE
150 SMA$34.29+8.50%ABOVE
200 SMA$34.05+9.27%ABOVE

Price Performance

1D+3.6%
1W+3.6%
1M+9.6%
3M+12.1%
6M+0.8%
YTD+9.8%
1Y-15.5%
3Y-9.6%
52-Week Trading Range49% from low
$37.20
52W Low$29.05
52W High$45.75

Technical Indicators

RSI (14)NEUTRAL
53.8
305070
VCP ScoreWARM
6/10
Base depth: 14.4%

Risk Profile

Beta
0.58
52W Vol
33%
ATR
$0.90
Max DD (1Y)
-34%

Volume Analysis

Today
37
50D Avg
71.5K
Vol Ratio
0.00x
Liquidity
ILLIQUID

Earnings Momentum

Q4'24+119%
$0.52
Q1'25-8%
$0.79
Q2'25+53%
$-0.30
Q3'25-166%
$-0.45
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+80.34%
5 Years:+14.37%
3 Years:+6.12%
TTM:+8.51%

Compounded Profit Growth

10 Years:—
5 Years:—
3 Years:—
TTM:-51.00%

Stock Price CAGR

10 Years:+7.59%
5 Years:-11.23%
3 Years:-9.57%
1 Year:-15.45%

Return on Equity

10Y Avg:-17.4%
5Y Avg:2.0%
3Y Avg:2.5%
Last Year:0.5%

Key Metrics

Market Cap$499M
Gross Margin78.9%
Net Margin4.8%
Piotroski F-Score4/9

More GMRE Analysis

Full Financial AnalysisDCF & Intrinsic ValueTotal Return Calculator

Compare With

GMRE vs HRHRCHCT

Data Dictionary

RS Rating (Relative Strength)

Measures 12-month price performance vs all stocks. Rating of 66 meansGMRE outperformed 66% of all stocks. Scores >80 indicate market leaders.

Beta

Measures volatility vs S&P 500. Beta of 0.58 means 42% less volatile than market.

Piotroski F-Score

9-point financial strength score based on profitability, leverage, and efficiency. Score of 4/9. Scores 7-9 = strong, 4-6 average, 0-3 = weak.

VCP (Volatility Contraction Pattern)

Measures base formation quality. Higher scores indicate tighter consolidation near pivot points. Score of 6/10 with WARM status.

Frequently Asked Questions

Is GMRE in an uptrend right now?

GMRE has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is GMRE overbought or oversold?

GMRE's RSI (14) is 54. The stock is in neutral territory, neither overbought nor oversold.

Is GMRE outperforming the market?

GMRE has a Relative Strength (RS) Rating of 66 out of 99. GMRE is performing about average compared to the market.

Where is GMRE in its 52-week range?

GMRE is trading at $37.20, which is 81% of its 52-week high ($45.75) and 49% above its 52-week low ($29.05).

How volatile is GMRE?

GMRE has a Beta of 0.58 and 52-week volatility of 33%. It's less volatile than the S&P 500 - generally more stable.